Avidity Partners Management LP - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 73 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avidity Partners Management LP ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$25,271,000
+8.3%
547,000
+1.7%
0.82%
-24.2%
Q3 2020$23,328,000
+13.4%
538,000
+38.6%
1.08%
-18.0%
Q2 2020$20,573,000
+336.2%
388,095
+83.9%
1.32%
+102.3%
Q1 2020$4,716,000211,0000.65%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 15,040$177,772,0000.69%
AlphaCentric Advisors LLC 50,000$591,0000.61%
Artemis Investment Management LLP 1,374,496$16,260,0000.18%
Knoll Capital Management, LLC 20,000$236,0000.14%
Game Plan Financial Advisors, LLC 11,280$133,0000.11%
Virtus ETF Advisers LLC 11,365$134,0000.05%
AllSquare Wealth Management LLC 5,527$65,0000.05%
Hennion & Walsh Asset Management, Inc. 34,231$405,0000.03%
Aquatic Capital Management LLC 10,000$118,0000.01%
Jump Financial, LLC 26,000$307,0000.01%
View complete list of BIOXCEL THERAPEUTICS INC shareholders